| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |